Article ESG The week in GRC: SEC’s Atkins reviews shareholder proposal rules as US AG’s launch energy investigation into tech giants Oct 17, 2025By Natalie Bannerman
Article Shareholders & activism Glass Lewis to ditch ‘benchmark’ or ‘house’ policies from 2027: what’s behind the shift Oct 16, 2025By Natalie Bannerman
Article Shareholders & activism How to craft proxies that gain the trust and support of your shareholders Oct 15, 2025By Staff writers
Article Careers People moves: SomniGroup promotes HR chief to legal as Shopify names new GC Oct 15, 2025By Natalie Bannerman
Article Regulatory & compliance The cost of a crypto promise: Seoul court orders Wemade to deliver $7mn in tokens Oct 14, 2025By Crescent Moran Chasteen
Article Regulatory & compliance The week in GRC: Elon Musk’s X reaches settlement with former Twitter execs as Atkins readies ‘innovation exemption’ crypto law Oct 10, 2025By Natalie Bannerman
Article Careers Nominees for the 2025 Corporate Governance Awards announced Oct 09, 2025By Natalie Bannerman
Article Careers People moves: Equitable Holdings promotes Kurt Meyers to legal chief as NioCorp welcomes new a GC Oct 08, 2025By Natalie Bannerman
Article Careers A career of influence: Hope Mehlman’s enduring legacy in corporate governance Oct 07, 2025By Natalie Bannerman
Article Shareholders & activism The week in GRC: ExxonMobil gets pushback on retail investor voting plan as Trump calls for Microsoft legal chief to exit Oct 03, 2025By Natalie Bannerman
Article Boardroom Preparing the board for 2026: More than half of directors want a peer replaced, survey finds Oct 02, 2025By Natalie Bannerman
Article Careers People moves: Michael Kaplan rejoins StandardAero as legal chief as Jenifer Kamocsay moves over to Carlsmed Oct 01, 2025By Natalie Bannerman
Article Boardroom Where were the directors? Why investors want to know how boards act in a corporate scandal Sep 29, 2025By Ricardo Jiménez Hernández
Article Boardroom The week in GRC: Disney shareholders demand answers over Jimmy Kimmel suspension as SEC clarifies position on quarterly reporting Sep 26, 2025By Natalie Bannerman
Article Regulatory & compliance When politics enters the lab: What Trump’s Tylenol autism claim means for legal leaders in medicine Sep 25, 2025By Natalie Bannerman
